Breast Cancer Liquid Biopsy Market by Biomarker (Circulating Tumor Cells (CTCs), Cell-free DNA (cfDNA), Extracellular Vesicles (EVs), and Other Circulating Biomarkers) and End User (Reference Laboratories, Hospitals and Physician Laboratories, and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global breast cancer liquid biopsy market expected to generate revenue of around USD 642.9 million by end of 2024, growing at a CAGR of around 22.9% between 2018 and 2024. Liquid biopsy assesses the presence of tumor cell-derived biomarkers such as cell-free DNA (cfDNA), circulating tumor cells, extracellular vesicles (exosomes) and their cargo, proteins, and circulating cell-free RNA (cfRNA).

29-Aug-2018 | Number of pages: 110 | Report Code: ZMR-3302 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the breast cancer liquid biopsy market on a global and regional level. The study provides historic data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the breast cancer liquid biopsy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the breast cancer liquid biopsy market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the breast cancer liquid biopsy market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product segment is benchmarked based on their market size, growth rate, and general attractiveness.

Global Breast Cancer Liquid Biopsy Market

The report provides company market share analysis in order to give a broader overview of the key players in the breast cancer liquid biopsy market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the breast cancer liquid biopsy market on the global and regional basis. 

The study provides a decisive view on the breast cancer liquid biopsy market by segmenting the market based on biomarkers, end users, and regions. The segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2024. The biomarker segment has been segmented into Circulating Tumor Cells (CTCs), Cell-free DNA (cfDNA), Extracellular Vesicles (EVs) and Other Circulating Biomarkers. Other circulating biomarkers include cell-free protein biomarkers and circulating RNA (ctRNA and cfRNA). Cell-free DNA segment holds the maximum share of the biomarker segment. Based on end user, breast cancer liquid biopsy market has been segmented into reference laboratories, hospitals and physician laboratories, other end users. Other end users include research institutes, academic research laboratories, pathology laboratories etc.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for pediatric medical devices based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Illumina, Cynvenio Biosystems, Inc., Genomic Health, Inc., Thermo Fisher Scientific Inc., Fluxion Biosciences, Inc., Biodesix, Inc., Guardant Health, Inc., and Isogen Life Science B.V. among others.

This report segments the global Breast Cancer Liquid Biopsy Market as follows:

Global Breast Cancer Liquid Biopsy Market: By Biomarker

  • Circulating Tumor Cells (CTCs)
  • Cell-free DNA (cfDNA)
  • Extracellular Vesicles (EVs)
  • Other Circulating Biomarkers (ctRNA, cfRNA and cell free proteins)

Global Breast Cancer Liquid Biopsy Market: By End User

  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Other End Users

Global Breast Cancer Liquid Biopsy Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Hospital Gowns Market by Type (Patient Gowns, Surgical Gowns, and Non-Surgical Gowns), by Risk Type (Minimal, Low, Moderate, and High), by Usability (Reusable, and Disposable), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5363 | Report Format:

The report covers forecast and analysis for the hospital gowns market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the hospital gowns market a...Read More

Prescription Lens Market by Type (Single Vision [Convex, Concave, and Cylindrical], Bifocal, Trifocal, Progressive, Workspace Progressives, and Others), by Application (Myopia, Hyperopia/ Hypermetropia, Astigmatism, and Presbyopia), by Coating (Anti-Reflective, Scratch Resistant Coating, Anti-Fog Coating, and Ultraviolet Treatment), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5361 | Report Format:

The report covers forecast and analysis for the prescription lens market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the prescription lens ma...Read More

Telepharmacy Market by Services (Remote Order Entry, Pharmacy Consultations, and Others), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5360 | Report Format:

The report covers forecast and analysis for the telepharmacy market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the telepharmacy market along...Read More

COVID-19 Sample Collection Kits Market by Product (Swabs, Viral Transport Media, Blood Collection Kits, Other Consumables), by Application (Diagnostics, Research), and Site of Collection (Hospitals & Clinics, Home Test) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5359 | Report Format:

The report covers forecast and analysis for the COVID-19 Sample Collection Kits market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the COVID-...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.